{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:14:34Z","timestamp":1777853674840,"version":"3.51.4"},"reference-count":14,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Intensive Care Med"],"published-print":{"date-parts":[[2003,1]]},"abstract":"<jats:p>A 61-year-old man developed a loculated fibropurulent pericarditis, a rare complication of bacteremia. This occurred as a complication of a Staphylococcal aureus bacteremia from a head and neck abscess following self-extraction of a tooth. Despite surgical intervention and placement of 2 pericardial drains, a refractory, inadequately drained infected pericardial effusion persisted. Although there is limited experience with thrombolytic therapy to dissolve a fibrin clot in the pericardium, break down loculated adhesions, and facilitate free drainage of infected material, lysis is well described in the management of exudative pleural effusions. After infusion of 30 mg of tissue plasminogen activator in 100 cc normal saline through the pericardial drain of the patient, a large amount of infected serosanginous material subsequently drained during the next 2 days. The patient became afebrile and culture negative, remained hemodynamically stable, and had resolution of his pericarditis and pericardial effusion on electrocardiogram and echocardiogram, respectively.<\/jats:p>","DOI":"10.1177\/0885066602239124","type":"journal-article","created":{"date-parts":[[2003,7,18]],"date-time":"2003-07-18T20:58:53Z","timestamp":1058561933000},"page":"47-51","source":"Crossref","is-referenced-by-count":11,"title":["Pericardial Infusion of Tissue Plasminogen Activator in Fibropurulent Pericarditis"],"prefix":"10.1177","volume":"18","author":[{"given":"Charles P.","family":"Reznikoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey T.","family":"Fish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas B.","family":"Coursin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2003,1,1]]},"reference":[{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"1. Alpert J. The importance of pharmacological profile of thrombolytic agents in clinical practice . Am J Card. 1991;68: 3E-7E .","DOI":"10.1016\/0002-9149(91)90298-Y"},{"key":"atypb2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI102046"},{"key":"atypb3","unstructured":"3. Goldsmith R, Sterling JA. Debridement using catalytic enzymes . Am Pract. 1951;2: 858-862 ."},{"key":"atypb4","unstructured":"4. Wright LT, Smith DH, Rothman M, Metzger WI, Quash ET. Use of streptokinase-dornase in certain surgical conditions . J Int Coll Surg. 1951;15: 286-299 ."},{"key":"atypb5","doi-asserted-by":"publisher","DOI":"10.1378\/chest.118.4.1158"},{"key":"atypb6","doi-asserted-by":"crossref","unstructured":"6. Davies RJO, Traill ZC, Gleeson FV. Randomized controlled trial of intrapleural streptokinase in community acquired pleural infection . Thorax. 1997;525: 416-421 .","DOI":"10.1136\/thx.52.5.416"},{"key":"atypb7","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.155.1.9001327"},{"key":"atypb8","doi-asserted-by":"publisher","DOI":"10.1007\/s001340050301"},{"key":"atypb9","unstructured":"9. Maynar J, Corral E, Manzano A, et al. Intrapericardial streptokinase in the management of purulent pneumococcal pericarditis . Intensive Care Med. 1997;23: 925-926 ."},{"key":"atypb10","doi-asserted-by":"publisher","DOI":"10.1136\/adc.80.3.275"},{"key":"atypb11","doi-asserted-by":"publisher","DOI":"10.1007\/s001340100918"},{"key":"atypb12","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(96)70462-2"},{"key":"atypb13","unstructured":"13. http:\/\/www.fda.gov\/cber\/ltr\/abbo12599.htm."},{"key":"atypb14","unstructured":"14. http:\/\/www.fda.gov\/medwatch\/safety\/1999\/strept.htm."}],"container-title":["Journal of Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0885066602239124","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0885066602239124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:55:46Z","timestamp":1777503346000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0885066602239124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["10.1177\/0885066602239124"],"URL":"https:\/\/doi.org\/10.1177\/0885066602239124","relation":{},"ISSN":["0885-0666","1525-1489"],"issn-type":[{"value":"0885-0666","type":"print"},{"value":"1525-1489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}